Previous 10 | Next 10 |
home / stock / casbf / casbf news
Chinese regulators have cleared clinical studies for two Covid-19 vaccines developed by local pharmaceutical companies, CanSino Biologics (OTCPK:CASBF) and CSPC Pharmaceutical (OTC:CHJTF), (OTCPK:CHPTY) (OTCPK:CSPCY). The National Medical Products Administration of China (NMPA) has given the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After months of sideways price action, Covid-19 vaccine play Ocugen (NASDAQ: OCGN ) stock is zooming higher once. Source: shutterstock.com/PhotobyTawat The big development is a likely Emergency Use Listin...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips On Oct. 5, InvestorPlace’s Louis Navellier argued that Ocugen (NASDAQ: OCGN ) stock needs a catalyst for it to break free. Source: shutterstock.com/PhotobyTawat One day earlier...
Doubling down his opposition to an early rollout of COVID-19 boosters, the Director-General of World Health Organization (WHO) urges rich countries with an excess supply of COVID-19 vaccines to halt their plans for booster shots through the end of the year. The head of the global agency Dr. T...
The World Health Organization (WHO) says that COVID-19 is likely “here to stay with us” as the virus mutates like flu viruses making its elimination unlikely. Speaking at a press briefing, Dr. Mike Ryan, the executive director of the WHO’s Health Emergencies Program said:...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips On a 12-month basis, Ocugen (NASDAQ: OCGN ) stock is still higher by over 1,500%. However, in the last six-months, the stock has remained sideways. Ocugen partnering with Bharat Biotech to bring Covaxin in the Unite...
jonathanfilskov-photography/E+ via Getty Images An inhaled formulation of a COVID-19 vaccine developed by CanSino Biologics (CASBF) triggered antibody responses similar to those from an injected version, according to a study published on the medical journal, The Lancet Infectious Disease, on&...
Messenger RNA-based technology that is highly effective in preventing Covid-19 can also be used for treatment of other diseases. High efficacy rates in preventing Covid-19 spark rush by Chinese companies into mRNA vaccines and treatments. At least one Chinese-made mRNA Covid vacci...
BGI Genomics of Shenzhen raised almost $300 million in a private placement for its next-gen sequencing services and genetic tests for medical institutions. New Horizon Health staged a $263 million IPO last week on the Hong Kong Exchange to support its early cancer screening tests. ...
Adenoviruses have long been used as tools in molecular biology. The first step in this process is to engineer the viral DNA that you need and make a lot of it. It's a fundamentally different process than the mRNA vaccines, with its own features (good and bad). For further de...